drugset / Trial / NCT00298506

Study to Assess the Efficacy and Safety of FK506 Combined With Mycophenolate Mofetil (MMF) in Lupus Nephritis (III/IV/V)

NCT00298506

Completed 120 enrolled Nanjing University School of Medicine
RandomizedParallel-groupOpen-labelTreatment

Summary

This is an open, prospective study to assess the efficacy and safety of Tacrolimus (FK506) combined with MMF in the treatment of class III, IV, V + IV or V + III lupus nephritis.

Timeline

Start
2005-09
Primary completion
2008-12
Completion
2009-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Mycophenolate Mofetil Small molecule 1 g
Comparator Tacrolimus Small molecule 4 mg

Indications